Immunotherapy has transformed the management of melanoma and is now a central component of care for patients with high-risk, unresectable, and metastatic disease. Immune checkpoint inhibitors targeting programmed death 1 (PD-1), cytotoxic T-lymphocyte-associat... ...

请注册登录后继续浏览